Detalles del producto
Lugar de origen: China.
Nombre de la marca: Sunshine
Certificación: ISO,COA
Número de modelo: No se puede
Condiciones de pago y envío
Cantidad de orden mínima: Negociación
Precio: Negociable
Detalles de empaquetado: Bolsa de papel de aluminio, tambor
Tiempo de entrega: 7 a 15 días
Condiciones de pago: T/T, L/C, D/A, Western Union
Capacidad de la fuente: Tones
No CAS:: |
No se puede |
Apariencia:: |
sólido blanco |
Fórmula molecular:: |
C16H16O4 |
Peso molecular:: |
272.296 |
El número de EINECS:: |
605-820-8 |
No de la DMA:: |
MFCD13152279: las condiciones de los productos |
No CAS:: |
No se puede |
Apariencia:: |
sólido blanco |
Fórmula molecular:: |
C16H16O4 |
Peso molecular:: |
272.296 |
El número de EINECS:: |
605-820-8 |
No de la DMA:: |
MFCD13152279: las condiciones de los productos |
Product Description:
Product Name: 2-hydroxy-3-methoxy-3,3-diphenylpropanoic acid CAS 178306-51-9
Synonyms:
hydroxymethoxydiphenylpropanoicacid;
rac-2-hydroxy-3-methoxy-3,3-diphenylpropionic acid;
Chemical & Physical Properties:
Appearance :white solid
Assay :≥99.0%
Density:1.25 g/cm3
Boiling Point: 430.3℃ at 760 mmHg
Flash Point:158.4℃
3-methoxy-2-hydroxy-3,3-diphenylpropionic acid is used to Ambrisentan intermediate.
Anrisentan is a selective endothelin receptor antagonist, which has the effects of reducing endogenous vasoconstriction, antiproliferative and anti-inflammatory. Anrisentan is a specific endothelin receptor A (ETA receptor) inhibitor developed by Gilead Science Company. It is a highly selective ETA receptor antagonist that can block the binding of ET and ETA, thereby blocking ETA-mediated pulmonary vasoconstriction and smooth muscle cell proliferation.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
